Filed under: Starbucks (SBUX), Procter and Gamble (PG), Kraft Foods’A’ (KFT)
I drink a lot of coffee. Is it good for me? Nah. And when I get a throbbing headache from it, sometimes there’s nothing better to do than just feed the monster and drink more. So, yeah, I drink too much coffee but what’s a father of five supposed to do?
So, when I read today’s BBC article, Coffee May Make Diabetes Worse, my ears perked up and I took note. The BBC quotes a study that suggests that “daily consumption of caffeine in coffee, tea or soft drinks increases blood sugar levels for people with type 2 diabetes.”
Huh? It sounds like caffeine is the culprit, not necessarily coffee. If tea and soft drinks also produce the same effect, it sounds unfair to blame the holy bean.
It gets better. The article continues, “the ten people who took part in the study were monitored with a tiny glucose monitor embedded under the skin.”
I always like studies that use a large, randomized subject pool. Ten people doesn’t quite cut it.
Even more: the patients were studied for a whopping 72 hours. Sorry, this study doesn’t quite pass the muster.
So, the lesson for investors? Don’t go out and short Kraft (NYSE: KFT) or Procter and Gamble (NYSE:PG), Nestle (OTC: NSRGY), or Starbucks (NASDAQ: SBUX) based on one data point. These coffee giants produce good product that like everything else in life, when taken in moderation, is not only enjoyable but life-enhancing.
Permalink | Email this | Comments
Entries (RSS)